222 related articles for article (PubMed ID: 19279311)
1. Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.
Durbin S; Mirabella G; Buncic JR; Westall CA
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):4011-6. PubMed ID: 19279311
[TBL] [Abstract][Full Text] [Related]
2. Contrast sensitivity is reduced in children with infantile spasms.
Mirabella G; Morong S; Buncic JR; Snead OC; Logan WJ; Weiss SK; Abdolell M; Westall CA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3610-5. PubMed ID: 17652730
[TBL] [Abstract][Full Text] [Related]
3. Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.
Dragas R; Westall C; Wright T
Doc Ophthalmol; 2014 Oct; 129(2):97-104. PubMed ID: 25008578
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
Westall CA; Wright T; Cortese F; Kumarappah A; Snead OC; Buncic JR
Neurology; 2014 Dec; 83(24):2262-8. PubMed ID: 25381295
[TBL] [Abstract][Full Text] [Related]
5. Reduced visual function associated with infantile spasms in children on vigabatrin therapy.
Hammoudi DS; Lee SS; Madison A; Mirabella G; Buncic JR; Logan WJ; Snead OC; Westall CA
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):514-20. PubMed ID: 15671276
[TBL] [Abstract][Full Text] [Related]
6. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
Acta Ophthalmol; 2014 Mar; 92(2):149-57. PubMed ID: 23387307
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
Akula JD
Neurology; 2015 Aug; 85(7):655-6. PubMed ID: 26283761
[No Abstract] [Full Text] [Related]
9. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis.
Biswas A; Yossofzai O; Vincent A; Go C; Widjaja E
Expert Rev Neurother; 2020 Dec; 20(12):1315-1324. PubMed ID: 33078964
[No Abstract] [Full Text] [Related]
10. Electroretinographic (ERG) responses in pediatric patients using vigabatrin.
Moskowitz A; Hansen RM; Eklund SE; Fulton AB
Doc Ophthalmol; 2012 Jun; 124(3):197-209. PubMed ID: 22426576
[TBL] [Abstract][Full Text] [Related]
11. Screening for vigabatrin (Sabril ®) retinal toxicity in children.
Brodie SE
Ophthalmic Genet; 2011 Nov; 32(4):193-5. PubMed ID: 21895515
[No Abstract] [Full Text] [Related]
12. VIGABATRIN TOXICITY IN INFANCY IS ASSOCIATED WITH RETINAL DEFECT IN ADOLESCENCE: A Prospective Observational Study.
Wright T; Kumarappah A; Stavropoulos A; Reginald A; Buncic JR; Westall CA
Retina; 2017 May; 37(5):858-866. PubMed ID: 27552291
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological Evidences of Visual Field Alterations in Children Exposed to Vigabatrin Early in Life.
Hébert-Lalonde N; Carmant L; Major P; Roy MS; Lassonde M; Saint-Amour D
Pediatr Neurol; 2016 Jun; 59():47-53. PubMed ID: 27105764
[TBL] [Abstract][Full Text] [Related]
14. Understanding and interpreting vision safety issues with vigabatrin therapy.
Plant GT; Sergott RC
Acta Neurol Scand Suppl; 2011; (192):57-71. PubMed ID: 22061181
[TBL] [Abstract][Full Text] [Related]
15. Aberrant mTOR signaling and disrupted autophagy: The missing link in potential vigabatrin-associated ocular toxicity?
Vogel KR; Ainslie GR; Pearl PL; Gibson KM
Clin Pharmacol Ther; 2017 Apr; 101(4):458-461. PubMed ID: 27864823
[TBL] [Abstract][Full Text] [Related]
16. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.
Ponjavic V; Andréasson S
Doc Ophthalmol; 2001 Jan; 102(1):63-72. PubMed ID: 11475366
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological evaluation of retinal function in children receiving vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
J Pediatr Ophthalmol Strabismus; 2011; 48(6):357-65. PubMed ID: 21261244
[TBL] [Abstract][Full Text] [Related]
18. Vigabatrin effect on inner retinal function.
Coupland SG; Zackon DH; Leonard BC; Ross TM
Ophthalmology; 2001 Aug; 108(8):1493-6; discussion 1497-8. PubMed ID: 11470707
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin: 2008 update.
Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
[TBL] [Abstract][Full Text] [Related]
20. Examining visual field defects in the paediatric population exposed to vigabatrin.
Spencer EL; Harding GF
Doc Ophthalmol; 2003 Nov; 107(3):281-7. PubMed ID: 14711160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
